AVE 20.0% 0.2¢ avecho biotechnology limited

pre announce, page-29

  1. 215 Posts.
    Be very careful reading big profits in this product for treating mastitis in dairy cows.
    I would like to see more clinical trial data and biochemistry before getting too excited.
    It states in the website that the product is "non-therapeutic" i.e. can't be used to treat. It may well be useful as an adjunct to treatment that may shorten the use of antibiotics? But antibiotics are still necessary to treat.
    Certainly mastitis is a major problem in the dairy industry and very difficult and complex to treat. I can make the above statements from the point of view of a veterinarian of 40 years experience and having at least 6 generations of dairy farmers in my genes. Dairy farmers are mostly very wise and a difficult market.
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.